Stockreport

Why Is Akebia (AKBA) Up After Strong Vafseo Data and Surging Q3 2025 Revenue? [Yahoo! Finance]

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF achieved net income of US$0.54 million after a prior net loss, supported by strong commercial results from its CKD anemia drug Vafseo. New clinical data presented in N [Read more]